Steward Partners Investment Advisory’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.53K | Buy |
|
|||||
|
2025
Q2 | $1.13K | Sell |
|
|||||
|
2025
Q1 | $2.32K | Hold |
|
|||||
|
2024
Q4 | $2.87K | Sell |
|
|||||
|
2024
Q3 | $13.9K | Buy |
|
|||||
|
2024
Q2 | $13.8K | Sell |
|
|||||
|
2024
Q1 | $77.1K | Buy |
|
|||||
|
2023
Q4 | $13.2K | Hold |
|
|||||
|
2023
Q3 | $11.3K | Hold |
|
|||||
|
2023
Q2 | $9.43K | Hold |
|
|||||
|
2023
Q1 | $10.1K | Hold |
|
|||||
|
2022
Q4 | $11.9K | Hold |
|
|||||
|
2022
Q3 | $11K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $3K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $10K | Hold |
|
|||||
|
2019
Q3 | $9K | Hold |
|
|||||
|
2019
Q2 | $8K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $127K | Buy |
|